Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06780475
Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma
Sponsor: Assistance Publique - Hôpitaux de Paris
View on ClinicalTrials.gov
Summary
The aim of the study is to test and validate in vitro a cell therapy approach for MCPyV+ Merkel Cell Carcinoma patients.
Official title: Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Merkel Cell Carcinoma of Skin
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
15
Start Date
2025-05-27
Completion Date
2027-05
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Locations (1)
Dermato-oncology Department, Ambroise Paré Hospital, APHP
Boulogne-Billancourt, France